Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fosbretabulin with Bevacizumab/Chemo in NSCLC
NCT00653939Phase 2Completed
- Sponsor
- Oncotelic Therapeutics, Inc.
- Start
- Mar 2008
- Primary completion
- Jul 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of fosbretabulin in non-small cell lung cancer (NSCLC), sponsored by Oncotelic Therapeutics, Inc.. Started Mar 2008; status: completed.
02
Drugs
fosbretabulin
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT00653939.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00653939.